Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 11, 2009, Pages 2345-2361

  Fantini, Jacques ^a   Barrantes, Francisco J ^b  

^a University of Mediterranée   (France)

^b UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

Author keywords

Cholesterol; Ganglioside; Glycosphingolipid; Lipid domain; Nicotinic acetylcholine receptor; Raft; Serotonin receptor; Sphingomyelin

Indexed keywords

CHAPERONE; CHOLESTEROL; CHOLINERGIC RECEPTOR; G PROTEIN COUPLED RECEPTOR; GANGLIOSIDE; ION CHANNEL; LIPID; MEMBRANE PROTEIN; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; SEROTONIN RECEPTOR; SPHINGOLIPID; SPHINGOMYELIN;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; BILAYER MEMBRANE; BINDING AFFINITY; BINDING SITE; CELL INTERACTION; CELL SURFACE; HUMAN; LIGAND BINDING; LIPID COMPOSITION; LIPID MEMBRANE; LIPID METABOLISM; LIPID RAFT; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NERVOUS TISSUE; NONHUMAN; PHYSICAL CHEMISTRY; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SYNAPTIC TRANSMISSION;

ANIMALS; CHOLESTEROL; HUMANS; PROTEIN CONFORMATION; RECEPTORS, NICOTINIC; RECEPTORS, SEROTONIN; SPHINGOLIPIDS; SYNAPTIC TRANSMISSION;

EID: 71549116093     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.08.016     Document Type: Review

References (191)

1. Woods A.S., and Jackson S.N. Brain tissue lipidomics: direct probing using matrix-assisted laser desorption/ionization mass spectrometry. AAPS J. 8 (2006) E391-E395
2. Fantini J., Garmy N., Mahfoud R., and Yahi N. Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases. Expert Rev. Mol. Med. 4 (2002) 1-22
3. Singer S.J., and Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science 175 (1972) 720-731
4. Hakomori S. The glycosynapse. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 225-232
5. Taïeb N., Yahi N., and Fantini J. Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium: bacterial targets linked to nutrient absorption. Adv. Drug Deliv. Rev. 56 (2004) 779-794
6. Berridge M.J. Inositol trisphosphate and diacylglycerol as second messengers. Biochem. J. 220 (1984) 345-630
7. Anderson R.G.W., and Jacobson K. A role for lipid shells in targeting proteins to caveolae, +rafts, and other lipid domains. Science 296 (2002) 1821-1825
8. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
9. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14 (1998) 111-136
10. Barenholz Y. Cholesterol and other membrane active sterols: from membrane evolution to "rafts". Prog. Lipid Res. 41 (2002) 1-5
11. Pike L.J. Lipid rafts: bringing order to chaos. J. Lipid Res. 44 4 (2003) 655-667
12. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32 (2003) 257-283
13. Danielsen E.M., and Hansen G.H. Lipid rafts in epithelial brush borders: atypical membrane microdomains with specialized functions. Biochim. Biophys. Acta 1617 (2003) 1-9
14. Thudichum J.L.W. The chemical constitution of the brain (1884), Baillère, Tindall, and Cox, London
15. Furukawa K., Tokuda N., Okuda T., Tajima O., and Furukawa K. Glycosphingolipids in engineered mice: insights into function. Seminars Cell Dev. Biol. 15 (2004) 389-396
16. Carter H.E., Glick F.J., Norris W.P., and Phillips G.E. Biochemistry of the sphingolipides. III. Structure of sphingosine. J. Biol. Chem. 170 (1947) 285-294
17. Futerman A.H., and Hannun Y.A. The complex life of simple sphingolipids. EMBO Rep. 5 (2004) 777-782
18. Carter H.E., Haines W.J., Ledyard W.E., and Norris W.P. Biochemistry of the sphingolipides. I. Preparation of sphingolipides from beef brain and spinal cord. J. Biol. Chem. 170 (1947) 77-82
19. Shapiro D., Segal H., and Flowers H.M. The total synthesis of sphingosine. J. Am. Chem. Soc. 80 (1958) 1194-1197
20. Karlsson K.A. Sphingolipid long chain bases. Lipids 5 (1970) 878-891
21. Karlsson K.A., Samuelsson B.E., and Steen G.O. Detailed structure of sphingomyelins and ceramides from different regions of bovine kidney with special reference to long-chain bases. Biochim. Biophys. Acta 316 (1973) 336-362
22. Tan R.X., and Chen J.H. The cerebrosides. Nat. Prod. Rep. 20 (2003) 509-534
23. Degroote S., Wolthoorn J., and van Meer G. The cell biology of glycosphingolipids. Seminars Cell Dev. Biol. 15 (2004) 375-387
24. Hikita T., Tadano-Aritomi K., Iida-Tanaka N., Levery S.B., Ishizuka I., and Hakomori S. Cationic glycosphingolipids in neuronal tissues and their possible biological significance. Neurochem. Res. 27 (2002) 575-581
25. Curatolo W. Glycolipid function. Biochim. Biophys. Acta 906 (1987) 137-160
26. Coetzee T., Fujita N., Dupree J., Shi R., Blight A., Suzuki K., Suzuki K., and Popko B. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 86 (1996) 209-219
27. Svennerholm L. The gangliosides. J. Lipid Res. 5 (1964) 145-155
28. Sonnino S., and Chigorno V. Ganglioside molecular species containing C18- and C20-sphingosine in mammalian nervous tissues and neuronal cell cultures. Biochim. Biophys. Acta 1469 (2000) 63-77
29. Hikita T., Tadano-Aritomi K., Iida-Tanaka N., Ishizuka I., and Hakomori S. De-N acetyllactotriaosylceramide as a novel cationic glycosphingolipid of bovine brain white matter: isolation and characterization. Biochemistry 44 (2005) 9555-9562
30. Mattjus P., and Slotte J.P. Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids?. Chem. Phys. Lipids (1996) 69-80
31. Brown R. Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. J. Cell Sci. (1998) 1-9
32. Brown D.A., and Brown E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 (2000) 17221-17224
33. Barenholz Y. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. Subcell. Biochem. (2004) 167-215
34. Ramstedt B., and Slotte J.P. Sphingolipids and the formation of sterol-enriched ordered membrane domains. Biochim. Biophys. Acta 1758 (2006) 1945-1956
35. Rose I.A., Hanson K.R., Wilkinson K.D., and Wimmer M.J. A suggestion for naming faces of ring compounds. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 2439-2441
36. Garmy N., Taïeb N., Yahi N., and Fantini J. Interaction of cholesterol with sphingosine: physicochemical characterization and impact on intestinal absorption. J. Lipid Res. 46 (2005) 36-45
37. Epand R.F., Thomas A., Brasseur R., Vishwanathan S.A., Hunter E., and Epand R.M. Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45 (2006) 6105-6114
38. Nag S., Balaji J., Madhu P.K., and Maiti S. Intermolecular association provides specific optical and NMR signatures for serotonin at intravesicular concentrations. Biophys. J. 94 (2008) 4145-4153
39. Adam G., and Delbrück M. Reduction of dimensionality in biological diffusion processes. In: Rich A., and Davidson N. (Eds). Structural Chemistry and Molecular Biology (1968), W.H. Freeman & Co 198-215
40. Krishnan K.S., and Balaram P. A nuclear magnetic resonance study of the interaction of serotonin with gangliosides. FEBS Lett. 63 (1976) 313-315
41. Price H.C., Byard C., Sims W., and Wilson R. Gangliosides and other lipid micelles. A study of amine binding by a dialysis/fluorescence method. Neurochem. Res. 4 (1979) 63-72
42. Yandrasitz J.R., Cohn R.M., Masley B., and Del Rowe D. Evaluation of the binding of serotonin by isolated CNS acidic lipids. Neurochem. Res. 5 (1980) 465-477
43. Matinyan N.S., Melikyan G.B., Arakelyan V.B., Kocharov S.L., Prokazova N.V., and Avakian T.M. Interaction of ganglioside-containing planar bilayers with serotonin and inorganic cations. Biochim. Biophys. Acta 984 (1989) 313-318
44. Beltramo D., Kivatinitz S., Lassaga E., and Arce A. GABA interaction with lipids in organic medium. Life Sci. 41 (1987) 733-739
45. Gayen A., and Mukhopadhyay C. Evidence for effect of GM1 on opioid peptide conformation: NMR study on leucine enkephalin in ganglioside-containing isotropic phospholipid bicelles. Langmuir 24 (2008) 5422-5432
46. González M., Lezcano N., Celis M.E., and Fidelio G.D. Interaction of alpha-MSH and substance P with interfaces containing gangliosides. Peptides 17 (1996) 269-274
47. Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes?. Trends Biochem. Sci. 11 (1986) 315-317
48. Rossetto O., and Montecucco C. Peculiar binding of botulinum neurotoxins. ACS Chem. Biol. 2 (2007) 96-98
49. Schwarzmann G. Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Semin, Cell Dev. Biol. 12 (2001) 163-171
50. Gorio A. Ganglioside enhancement of neuronal differentiation, plasticity, and repair. CRC Crit. Rev. Clin. Neurobiol. 2 (1986) 241-296
51. Ferrari G., Fabris M., and Gorio A. Gangliosides enhance neurite outgrowth in PC12 cells. Brain Res. 284 (1983) 215-221
52. Ichikawa N., Iwabuchi K., Kurihara H., Ishii K., Kobayashi T., Sasaki T., Hattori N., Mizuno Y., Hozumi K., Yamada Y., and Arikawa-Hirasawa E. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J. Cell Sci. 122 (2009) 289-299
53. Berry-Kravis E., and Dawson G. Possible role of gangliosides in regulating an adenylate cyclase-linked 5-hydroxytryptamine (5-HT1) receptor. J. Neurochem. 45 (1985) 1739-1747
54. Crain S.M., and Shen K.F. GM1 ganglioside-induced modulation of opioid receptor-mediated functions. Ann. N. Y. Acad. Sci. 845 (1998) 106-125
55. Crain S.M., and Shen K.F. Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice. Brain Res. 995 (2004) 260-266
56. Radin N.S. Killing tumours by ceramide-induced apoptosis: a critique of available drugs. Biochem. J. 371 (2003) 243-256
57. Kobayashi T., Takahashi M., Nagatsuka Y., and Hirabayashi Y. Lipid rafts: new tools and a new component. Biol. Pharm. Bull. 29 (2006) 1526-1531
58. Ottico E., Prinetti A., Prioni S., Giannotta C., Basso L., Chigorno V., and Sonnino S. Dynamics of membrane lipid domains in neuronal cells differentiated in culture. J. Lipid Res. 44 (2003) 2142-2151
59. Singh R.D., Holicky E.L., Cheng Z.J., Kim S.Y., Wheatley C.L., Marks D.L., Bittman R., and Pagano R.E. Inhibition of caveolar uptake, SV40 infection, and beta1-integrin signaling by a nonnatural glycosphingolipid stereoisomer. J. Cell Biol. (2007) 895-901
60. Hirai M., Iwase H., Arai S., Takizawa T., and Hayashi K. Interaction of gangliosides with proteins depending on oligosaccharide chain and protein surface modification. Biophys. J. 74 (1998) 1380-1387
61. Mullin B.R., Fishman P.H., Lee G., Aloj S.M., Ledley F.D., Winand R.J., Kohn L.D., and Brady R.O. Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc. Natl. Acad. Sci. U.S.A. 73 (1976) 842-846
62. Cheresh D.A., Pytela R., Pierschbacher M.D., Klier F.G., Ruoslahti E., and Reisfeld R.A. An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2. J. Cell Biol. 105 (1987) 1163-1173
63. Kabayama K., Sato T., Saito K., Loberto N., Prinetti A., Sonnino S., Kinjo M., Igarashi Y., and Inokuchi J. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 13678-13683
64. Miljan E.A., Meuillet E.J., Mania-Farnell B., George D., Yamamoto H., Simon H.G., and Bremer E.G. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J. Biol. Chem. 277 (2002) 10108-10113
65. Bremer E.G., Hakomori S., Bowen-Pope D.F., Raines E., and Ross R. Ganglioside-mediated modulation of cell growth, growth factor binding and receptor phosphorylation. J. Biol. Chem. 259 (1984) 6818-6825
66. Rebbaa A., Chou P.M., and Bremer E.G. Modulation of growth factor response in brain tumors by complex carbohydrates. Bull. Cancer 91 (2004) E15-E60
67. Wu G., Lu Z.H., Alfinito P., and Ledeen R.W. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions. Neurochem. Res. 22 (1997) 1281-1289
68. Wu G., Lu Z.H., and Ledeen R.W. Interaction of the delta-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode. Brain Res. Mol. Brain Res. 44 (1997) 341-346
69. Kielczynski W., Bartholomeusz R.K., and Harrison L.C. Characterization of ganglioside associated with the thyrotrophin receptor. Glycobiology 4 (1994) 791-796
70. Baier C.J., and Barrantes F.J. Sphingolipids are necessary for nicotinic acetylcholine receptor export in the early secretory pathway. J. Neurochem. 101 (2007) 1072-1084
71. Gimpl G., Burger K., and Fahrenholz F. Cholesterol as modulator of receptor function. Biochemistry 36 (1997) 10959-10974
72. Burger K., Gimpl G., and Fahrenholz F. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57 (2000) 1577-1592
73. Barrantes F.J. Cholesterol effects on nicotinic acetylcholine receptor. J. Neurochem. 103 Suppl. 1 (2007) 72-80
74. Mitchell D.C., Straume M., Miller J.L., and Litman B.J. Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry 29 (1990) 9143-9149
75. Albert A.D., Young J.E., and Yeagle P.L. Rhodopsin-cholesterol interactions in bovine rod outer segment disk membranes. Biochim. Biophys. Acta 1285 (1996) 47-55
76. Klein U., and Fahrenholz F. Reconstitution of the myometrial oxytocin receptor into proteoliposomes: dependence of oxytocin binding on cholesterol. Eur. J. Biochem. 220 (1994) 559-567
77. Klein U., Gimpl G., and Fahrenholz F. Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34 (1995) 13784-13793
78. Marsh D. ESR spin label studies of lipid-protein interactions. In: Watts A., and De Pont J.H.H.M. (Eds). Progress in Protein-lipid Interactions (1985), Elsevier Science Publ. B.V., Amsterdam 143-172
79. O 'Neill M.F., Dourish C.T., Tye S.J., and Iversen S.D. Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey. Brain Res. 534 (1990) 287-290
80. Harro J., and Vasar E. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur. J. Pharmacol. 193 (1991) 379-381
81. Paila Y.D., Tiwari S., and Chattopadhyay A. Are specific nonannular cholesterol binding sites present in G-protein coupled receptors?. Biochim. Biophys. Acta 1788 (2009) 295-302
82. Whitaker-Azmitia P.M. The discovery of serotonin and its role in neuroscience. Neuropsychopharmacol. 21 (2002) 2S-8S
83. Maresca M., Derghal A., Carravagna C., Dudin S., and Fantini J. Controlled aggregation of adenine by sugars: physicochemical studies, molecular modelling simulations of sugar-aromatic CH-pi stacking interactions, and biological significance. Phys. Chem. Chem. Phys. 10 (2008) 2792-2800
84. Nishio M., Umezawa Y., Hirota M., and Takeuchi Y. The CH/Pi interaction: significance in molecular recognition. Tetrahedron 51 (1995) 8665-8701
85. Roth B.L. Multiple serotonin receptors: clinical and experimental aspects. Ann. Clin. Psychiatry 6 (1994) 67-78
86. LeGreve T.A., Baquero E.E., and Zwier S.T. Infrared and ultraviolet spectral signatures and conformational preferences of jet-cooled serotonin. J. Am. Chem. Soc. 129 (2007) 4028-4038
87. Nichols D.E., and Nichols C.D. Serotonin receptors. Chem. Rev. 108 (2008) 1614-1641
88. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71 (2002) 533-554
89. Renner U., Glebov K., Lang T., Papusheva E., Balakrishnan S., Keller B., Richter D.W., Jahn R., and Ponimaskin E. Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipid microdomains depends on its palmitoylation and is involved in receptor-mediated signaling. Mol. Pharmacol. 72 (2007) 502-513
90. Dreja K., Voldstedlund M., Vinten J., Tranum-Jensen J., Hellstrand P., and Swärd K. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1267-1272
91. Sjögren B., and Svenningson P. Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells. Acta Physiol. 190 (2007) 47-53
92. Ponimaskin E.G., Heine M., Joubert L., Sebben M., Bickmeyer U., Richter D.W., and Dumuis A. The 5-hydroxytryptamine(4a) receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity. J. Biol. Chem. 277 (2002) 2534-2546
93. Yun H.M., Kim S., Kim H.J., Kostenis E., Kim J.I., Seong J.Y., Baik J.H., and Rhim H. The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn. J. Biol. Chem. 282 (2007) 5496-5505
94. Harder T., Scheiffele P., Verkade P., and Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141 (1998) 929-942
95. Magnani F., Tate C.G., Wynne S., Williams C., and Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J. Biol. Chem. 279 (2004) 38770-38778
96. Chini B., and Parenti M. G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?. J. Mol. Endocrinol. 32 (2004) 325-338
97. Pucadyil T.J., and Chattopadhyay A. Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus. Biochim. Biophys. Acta 1663 (2004) 188-200
98. Papoucheva E., Dumuis A., Sebben M., Richter D.W., and Ponimaskin E.G. The 5-hydroxytryptamine(1A) receptor is stably palmitoylated, and acylation is critical for communication of receptor with Gi protein. J. Biol. Chem. 279 (2004) 3280-3291
99. Bhatnagar A., Sheffler D.J., Kroeze W.K., Compton-Toth B., and Roth B.L. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J. Biol. Chem. 279 (2004) 34614-34623
100. Sjögren B., and Svenningsson P. Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors. FEBS Lett. 581 (2007) 5115-5121
101. Bourne H.R. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9 (1997) 134-142
102. Pucadil T.J., Kalipatnapu S., and Chattopadhyay A. The serotonin(1a) receptor: a representative membre of the serotonin receptor family. Cell. Mol. Neurobiol. 25 (2005) 553-5580
103. Lopez J.J., and Lorch M. Location and orientation of serotonin receceptor 1a agonists in model and complex lipid membranes. J. Biol. Chem. 283 (2008) 7813-7822
104. 2-adrenergic receptor. Structure 16 (2008) 897-905
105. Thompson A.J., and Lummis S.C.R. The 5-HT3 receptor as a therapeutic target, Expert Opin. Ther. Targets 11 (2007) 527-540
106. Derkach V., Surprenant A., and North R.A. 5-HT3 receptors are membrane ion channels. Nature 339 (1989) 706-709
107. Eisensamer B., Uhr M., Meyr S., Gimpl G., Deiml T., Rammes G., Lambert J.J., Zieglgänsberger W., Holsboer F., and Rupprecht R. Antidepressants and antipsychotic drugs colocalize with 5-HT3 Receptors in raft-like domains. J. Neurosci. 25 (2005) 10198-10206
108. Barrantes F.J. Modulation of nicotinic acetylcholine receptor function through the outer and middle rings of transmembrane domains. Curr. Opin. Drug Discov. Devel. 6 (2003) 620-632
109. Barrantes F.J. Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Res. Brain Res. Rev. 47 (2004) 71-95
110. Marsh D., and Barrantes F.J. Immobilized lipid in acetylcholine receptor-rich membranes from Torpedo marmorat. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 4329-4333
111. Abadji V.C., Reines D.E., Dalton L.A., and Miller K.M. Lipid-protein interactions and protein dynamics in vesicles containing the nicotinic acetylcholine receptor: a study with ethanol. Biochim. Biophys. Acta 1194 (1994) 25-34
112. Arias H.R., Sankaram M.B., Marsh D., and Barrantes F.J. Effect of local anaesthetics on steroid-nicotinic acetylcholine receptor interactions in native membranes of Torpedo marmorata electric organ. Biochim. Biophys. Acta 1027 (1990) 287-294
113. Dreger M., Krauss M., Herrmann A., and Hucho F. Interactions of the nicotinic acetylcholine receptor transmembrane segments with the lipid bilayer in native receptor-rich membranes. Biochemistry 36 (1997) 839-847
114. Ellena J.F., Blazing M.A., and McNamee M.G. Lipid-protein interactions in reconstituted membranes containing acetylcholine receptor. Biochemistry 22 (1983) 5523-5535
115. Horváth L.I., Arias H.R., Hankovszky H.O., Hideg K., Barrantes F.J., and Marsh D. Association of spin-labeled local anesthetics at the hydrophobic surface of acetylcholine receptor in native membranes from Torpedo marmorat. Biochemistry 29 (1990) 8707-8713
116. Marsh D., Watts A., and Barrantes F.J. Phospholipid chain immobilization and steroid rotational immobilization in acetylcholine receptor-rich membranes from Torpedo marmorata. Biochim. Biophys. Acta 645 (1981) 97-101
117. Bhushan A., and McNamee M.G. Correlation of phospholipid structure with functional effects on the nicotinic acetylcholine receptor. A modulatory role for phosphatidic acid. Biophys. J. 64 (1993) 716-723
118. Jones O.T., and McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 27 (1988) 2364-2374
119. Rousselet A., Devaux P.F., and Wirtz K.W. Free fatty acids and esters can be immobilized by receptor rich membranes from Torpedo marmorata but not phospholipid acyl chains. Biochem. Biophys. Res. Commun. 90 (1979) 871-877
120. Epstein M., and Racker E. Reconstitution of carbamylcholine-dependent sodium ion flux and desensitization of the acetylcholine receptor from Torpedo californica. J. Biol. Chem. 253 (1978) 6660-6662
121. Criado M., Eibl H., and Barrantes F.J. Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 21 (1982) 3622-3629
122. Criado M., Eibl H., and Barrantes F.J. Functional properties of the acetylcholine receptor incorporated in model lipid membranes. Differential effects of chain length and head group of phospholipids on receptor affinity states and receptor-mediated ion translocation. J. Biol. Chem. 259 (1984) 9188-9198
123. Ochoa E.L., Dalziel A.W., and McNamee M.G. Reconstitution of acetylcholine receptor function in lipid vesicles of defined composition. Biochim. Biophys. Acta 272 (1983) 151-162
124. Jones O.T., Eubanks J.H., Earnest J.P., and McNamee M.G. A minimum number of lipids are required to support the functional properties of the nicotinic acetylcholine receptor. Biochemistry 27 (1988) 3733-3742
125. Zingsheim H.P., Barrantes F.J., Frank J., Haenicke W., and Neugebauer D.C. Direct structural localization of two toxin-recognition sites on an ACh receptor protein. Nature 299 (1982) 81-84
126. Zingsheim H.P., Neugebauer D.C., Frank J., Hanicke W., and Barrantes F.J. Dimeric arrangement and structure of the membrane-bound acetylcholine receptor studied by electron microscopy. EMBO J. 1 (1982) 541-547
127. Mitra A.K., McCarthy M.P., and Stroud R.M. Three-dimensional structure of the nicotinic acetylcholine receptor and location of the major associated 43-kD cytoskeletal protein, determined at 22 Å by low dose electron microscopy and x-ray diffraction to 12.5 Å. J. Cell Biol. 109 (1989) 755-774
128. Toyoshima C., and Unwin N. Three-dimensional structure of the acetylcholine receptor by cryoelectron microscopy and helical image reconstruction. J. Cell Biol. 111 (1990) 2623-2635
129. Prince R.J., and Sine S.M. The ligand binding domains of the niotinic acetylcholine receptor. In: Barrantes F.J. (Ed). The nicotinic acetylcholine receptor: current views and future trends (1998), Landes Bioscience, Austin, Texas 31-59
130. Valenzuela C.F., Weign P., Yguerabide J., and Johnson D.A. Transverse distance between the membrane and the agonist binding sites on the Torpedo acetylcholine receptor: a fluorescence study. Biophys. J. 66 (1994) 674-682
131. Unwin N. Nicotinic acetylcholine receptor at 9 Å resolution. J. Mol. Biol. 229 (1993) 1101-1124
132. Unwin N. Neurotransmitter action: opening of ligand-gated ion channels. Cell 72 (1993) 31-41
133. Unwin N., and The Croonian Lecture. Nicotinic acetylcholine receptor and the structural basis of fast synaptic transmission. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355 2000 (2000) 1813-1829
134. Changeux J.-P., and Edelstein S.J. Allosteric receptors after 30 years. Neuron 21 (1998) 959-980
135. Opella S.J., Marassi F.M., Gesell J.J., Valente A.P., Kim Y., Oblatt-Montal M., and Montal M. Structures of the M2 channel-lining segments from nicotinic acetylcholine and NMDA receptors by NMR spectroscopy. Nat. Struct. Biol. 6 (1999) 374-379
136. Pashkov V.S., Maslennikov I.V., Tchikin L.D., Efremov R.G., Ivanov V.T., and Arseniev A.S. Spatial structure of the M2 transmembrane segment of the nicotinic acetylcholine receptor alpha-subunit. FEBS Lett. 457 (1999) 117-121
137. Miyazawa A., Fujiyoshi Y., and Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 423 (2003) 949-955
138. Unwin N. Refined structure of the nicotinic acetylcholine receptor at 4 Å resolution. J. Mol. Biol. 346 (2005) 967-989
139. Unwin N. Acetylcholine receptor channel imaged in the open state. Nature 373 (1995) 37-43
140. Blanton M.P., and Cohen J.B. Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 31 (1992) 3738-3750
141. Blanton M.P., and Cohen J.B. Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry 33 (1994) 2859-2872
142. 125I]TIDPC/16. Biochemistry 37 (1998) 14545-14555
143. Baezinger J.E., and Methot N. Fourier transform infrared and hydrogen/deuterium exchange reveal an exchange-resistant core of α-helical peptide hydrogens in the nicotinic acetylcholine receptor. J. Biol. Chem. 270 (1996) 29129-29137
144. Corbin J., Methot N., Wang H.H., Baenziger J.E., and Blanton M.P. Secondary structure analysis of individual transmembrane segments of the nicotinic acetylcholine receptor by circular dichroism and Fourier transform infrared spectroscopy. J. Biol. Chem. 273 (1998) 771-777
145. Lugovskoy A.A., Maslennikov I.V., Utkin Y.N., Tsetlin V.I., Cohen J.B., and Arseniev A.S. Spatial structure of the M3 transmembrane segment of the nicotinic acetylcholine receptor a subunit. Eur. J. Biochem. 255 (1998) 455-461
146. Williamson P.T.F., Zandomeneghi G., Barrantes F.J., Watts A., and Meier B.H. Structural and dynamic studies of the γ-M4 transmembrane domain of the nicotinic acetylcholine receptor. Mol. Membr. Biol. 22 (2005) 485-496
147. Brejc K., van Dijk W.J., Klaassen R.V., Schuurmans M., van Der O.J., Smit A.B., and Sixma T.K. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411 (2001) 269-276
148. Dellisanti C.D., Yao Y., Stroud J.C., Wang Z.-Z., and Chen L. Crystal structure of the extracellular domain of nAChR a1 bound to a-bungarotoxin at 1.94 Å resolution. Nat. Neurosci. 10 (2007) 953-962
149. Bonini I.C., Antollini S.S., Gutierrez-Merino C., and Barrantes F.J. Sphingomyelin composition and physical asymmetries in native acetylcholine receptor-rich membranes. Eur. Biophys. J. 31 (2002) 417-427
150. Mantipragada S.B., Horvath L.I., Arias H.R., Schwarzmann G., Sandhoff K., Barrantes F.J., and Marsh D. Lipid-protein interactions and effect of local anesthetics in acetylcholine receptor-rich membranes from Torpedo marmorata electric organ. Biochemistry 42 (2003) 9167-9175
151. Barrantes F.J., Antollini S.S., Blanton M.P., and Prieto M. Topography of nicotinic acetylcholine receptor membrane-embedded domains. J. Biol. Chem. (2000) 37333-37339
152. Antollini S.S., Soto M.A., Bonini de Romanelli I.C., Gutierrez-Merino C., Sotomayor P., and Barrantes F.J. Physical state of bulk and protein-associated lipid in nicotinic acetylcholine receptor-rich membrane studied by laurdan generalized polarization and fluorescence energy transfer. Biophys. J. 70 (1996) 1275-1284
153. Antollini S.S., and Barrantes F.J. Unique effects of different fatty acid species on the physical properties of the torpedo acetylcholine receptor membrane. J. Biol. Chem. 277 (2002) 1249-1254
154. Fong T.M., and McNamee M.G. Stabilization of acetylcholine receptor secondary structure by cholesterol and negatively charged phospholipids in membranes. Biochemistry 26 (1987) 3871-3880
155. Andreasen T.J., and McNamee M.G. Inhibition of ion permeability control properties of acetylcholine receptor from Torpedo californica by long-chain fatty acids. Biochemistry 19 (1980) 4719-4726
156. Marsh D., and Horváth L.I. Structure, dynamics and composition of the lipid-protein interface. Perspectives from spin-labelling. Biochim Biophys Acta 1376 (1998) 267-296
157. Brown E.R., and Subbaiah P.V. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts. Lipids 29 (1994) 825-829
158. Mielke D.L., and Wallace B.A. Secondary structural analyses of the nicotinic acetylcholine receptor as a test of molecular model. J. Biol. Chem. 263 (1988) 3177-3182
159. Aslanian D., Grof P., Galzi J.L., and Changeux J.P. A Raman spectroscopic study of acetylcholine receptor-rich membranes from Torpedo marmorata. Interaction of the receptor with carbamylcholine and (+)-tubocurarine. Biochim. Biophys. Acta 1148 (1993) 291-302
160. McCarthy M.P., and Stroud R.M. Conformational states of the nicotinic acetylcholine receptor from Torpedo californica induced by the binding of agonists, antagonists, and local anesthetics. Equilibrium measurements using tritium-hydrogen exchange. Biochemistry 28 (1989) 40-48
161. Barrantes F.J. Agonist-mediated changes of the acetylcholine receptor in its membrane environment. J. Mol. Biol. 124 (1978) 1-26
162. Galzi J.L., Revah F., Bouet F., Ménez A., Goeldner M., Hirth C., and Changeux J.P. Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5051-5055
163. 125I]iodophenyl) diazirine. Biochemistry 27 (1988) 8741-8751
164. Castresana J., Fernandez-Ballester G., Fernández A.M., Laynez J.L., Arrondo J.L.R., Ferragut J.A., and González-Ros J.M. Protein structural effects of agonist binding to the nicotinic acetylcholine receptor. FEBS Lett. 314 (1992) 171-175
165. Fernandez-Ballester G., Castresana J., Fernandez A.M., Arrondo J.L.R., Ferragut J.A., and Gonzalez-Ros J.M. A role for cholesterol as a structural effector of the nicotinic acetylcholine receptor. Biochemistry 33 (1994) 4065-4071
166. Méthot N., McCarthy M.P., and Baenziger J.E. Secondary structure of the nicotinic acetylcholine receptor: implications for structural models of a ligand-gated ion channel. Biochemistry 33 (1994) 7709-7717
167. Görne-Tschelnokow U., Strecker A., Kaduk C., Naumann D., and Hucho F. The transmembrane domains of the nicotinic acetylcholine receptor contain α-helical and β structures. EMBO J. 13 (1994) 338-341
168. Baezinger J.E., and Méthot N. Fourier transform infrared and hydrogen/deuterium exchange reveal an exchange-resistant core of α-helical peptide hydrogens in the nicotinic acetylcholine receptor. J. Biol. Chem. 270 (1996) 29129-29137
169. Méthot N., Ritchie B.D., Blanton M.P., and Baenziger J.E. Structure of the pore-forming transmembrane domain of a ligand-gated ion channel. J. Biol. Chem. 276 (2001) 23726-23732
170. Méthot N., Demers C.N., and Baenziger J.E. Structure of both the ligand- and lipid-dependent channel-inactive states of the nicotinic acetylcholine receptor probed by FTIR spectroscopy and hydrogen exchange. Biochemistry 34 (1995) 15142-15149
171. Sunshine C., and McNamee M.G. Lipid modulation of nicotinic acetylcholine receptor function: The role of membrane lipid composition and fluidity. Biochim. Biophys. Acta 1191 (1994) 59-64
172. González-Ros J.M., Llanillo M., Paraschos A., and Martínez-Carrion M. Lipid environment of acetylcholine receptor from Torpedo californica. Biochemistry 21 (1982) 3467-3474
173. Bonini de Romanelli I.C., Roccamo de Fernandez A.M., and Barrantes F.J. Extraction of peripheral proteins is accompanied by selective depletion of certain glycerophospholipid classes and changes in the phosphorylation pattern of acetylcholine-receptor-rich-membrane proteins. Biochem. J. 245 (1987) 111-118
174. Hammache D., Piéroni G., Maresca M., Ivaldi S., Yahi N., and Fantini J. Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactions. Methods Enzymol. 312 (2000) 495-506
175. Mahfoud R., Garmy N., Maresca M., Yahi N., Puigsever A., and Fantini J. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J. Biol. Chem. 277 (2002) 11292-11296
176. Fantini J., Garmy N., and Yahi N. Prediction of glycolipid-binding domains from the amino acid sequence of lipid raft-associated proteins: application to HpaA, a protein involved in the adhesion of Helicobacter pylori to gastrointestinal cells. Biochemistry 45 (2006) 10957-10962
177. Fantini J. How sphingolipids bind and shape proteins: molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains. Cell. Mol. Life Sci. 60 (2003) 1027-1032
178. Snook C.F., Jones J.A., and Hannun Y.A. Sphingolipid-binding proteins. Biochim. Biophys. Acta 1761 (2006) 927-946
179. Fantini J. Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications. Curr. Med. Chem. 14 (2007) 2911-2917
180. Levy M., Garmy N., Gazit E., and Fantini J. The minimal amyloid-forming fragment of the islet amyloid polypeptide is a glycolipid-binding domain. FEBS J. 273 (2006) 5724-5735
181. Taïeb N., Maresca M., Guo X.J., Garmy N., Fantini J., and Yahi N. The first extracellular domain of the tumour stem cell marker CD133 contains an antigenic ganglioside-binding motif. Cancer Lett. (2009) doi:10.1016/j.canlet.2009.01.013.
182. Matsubara T., Iida M., Tsumuraya T., Fujii I., and Sato T. Selection of a carbohydrate-binding domain with a helix-loop-helix structure. Biochemistry 47 (2008) 6745-6751
183. Sakamoto H., Okamoto K., Aoki M., Kato H., Katsume A., Ohta A., Tsukuda T., Shimma N., Aoki Y., Arisawa M., Kohara M., and Sudoh M. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nature Chem. Biol. 1 (2005) 333-337
184. Chakrabandhu K., Huault S., Garmy N., Fantini J., Stebe E., Mailfert S., Marguet D., and Hueber A.O. The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand. Cell Death Differ. 15 (2008) 1824-1837
185. Hebbar S., Lee E., Manna M., Steinert S., Kumar G.S., Wenk M., Wohland T., and Kraut R. A fluorescent sphingolipid binding domain peptide probe interacts with sphingolipids and cholesterol-dependent raft domains. J. Lipid Res. 49 (2008) 1077-1089
186. Sarnataro D., Campana V., Paladino S., Stornaiulo M., Nitsch L., and Zurzolo C. PrPc association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol. Cell. Biol. 15 (2004) 4031-4042
187. Cerný J., and Hobza P. Non-covalent interactions in biomacromolecules. Phys. Chem. Chem. Phys. 9 (2007) 5291-5303
188. Ma B., Elkayam T., Wolfson H., and Nussinov R. Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces. Proc. Natl. Acad. Sci. U.S.A. 2003 100 (2003) 5772-5777
189. Ellis R.J. Do molecular chaperones have to be proteins?. Biochem. Biophys. Res. Commun. 238 (1997) 687-692
190. Allen J.A., Halverson-Tamboli R.A., and Rasenick M.M. Lipid raft microdomains and neurotransmitter signalling. Nat. Rev. Neurosci. (2007) 128-140
191. Liu X., Xu Y., Li H., Wang X., Jiang H., and Barrantes F.J. Mechanics of channel gating of the nicotinic acetylcholine receptor. PLoS Computat. Biol. 4 (2008) 100-110